These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8885142)

  • 1. High prevalence of the FVR506Q mutation causing APC resistance in a region of southern Sweden with a high incidence of venous thrombosis.
    Zöller B; Norlund L; Leksell H; Nilsson JE; von Schenck H; Rosén U; Jepsson JO; Dahlbäck B
    Thromb Res; 1996 Sep; 83(6):475-7. PubMed ID: 8885142
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia.
    De Stefano V; Leone G
    Haematologica; 1995; 80(4):344-56. PubMed ID: 7590506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inherited resistance to activated protein C caused by presence of the FV:Q506 allele as a basis of venous thrombosis.
    Dahlbäck B; Zöller B; Hillarp A
    Haemostasis; 1996 Oct; 26 Suppl 4():301-14. PubMed ID: 8979136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis.
    Bertina RM; Reitsma PH; Rosendaal FR; Vandenbroucke JP
    Thromb Haemost; 1995 Jul; 74(1):449-53. PubMed ID: 8578504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis.
    Dahlbäck B
    Thromb Haemost; 1995 Jul; 74(1):139-48. PubMed ID: 8578447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to activate protein C, the Arg506 to Gln mutation in the factor V gene, and venous thrombosis. Functional tests and DNA-based assays, pros and cons.
    Dahlbäck B
    Thromb Haemost; 1995 May; 73(5):739-42. PubMed ID: 7482395
    [No Abstract]   [Full Text] [Related]  

  • 7. Probability of recurrence of thrombosis in patients with and without factor V Leiden.
    Rintelen C; Pabinger I; Knöbl P; Lechner K; Mannhalter C
    Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of original and modified APC-resistance tests in unselected outpatients with clinically suspected thrombosis and in healthy controls.
    Svensson PJ; Zöller B; Dahlbäck B
    Thromb Haemost; 1997 Feb; 77(2):332-5. PubMed ID: 9157592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apparent different thrombotic tendency in patients with factor V Leiden and protein C deficiency due to selection of patients.
    Lensen RP; Rosendaal FR; Koster T; Allaart CF; de Ronde H; Vandenbroucke JP; Reitsma PH; Bertina RM
    Blood; 1996 Dec; 88(11):4205-8. PubMed ID: 8943855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor V Leiden: an additional risk factor for thrombosis in protein S deficient families?
    Koeleman BP; van Rumpt D; Hamulyák K; Reitsma PH; Bertina RM
    Thromb Haemost; 1995 Aug; 74(2):580-3. PubMed ID: 8584987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent thrombosis due to compound heterozygosity for factor V Leiden and factor V deficiency.
    Zehnder JL; Jain M
    Blood Coagul Fibrinolysis; 1996 Apr; 7(3):361-2. PubMed ID: 8735145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C-deficient patients. The French Network on the behalf of INSERM.
    Gandrille S; Greengard JS; Alhenc-Gelas M; Juhan-Vague I; Abgrall JF; Jude B; Griffin JH; Aiach M
    Blood; 1995 Jul; 86(1):219-24. PubMed ID: 7795227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homozygous APC-resistance combined with inherited type I protein S deficiency in a young boy with severe thrombotic disease.
    Zöller B; He X; Dahlbäck B
    Thromb Haemost; 1995 May; 73(5):743-5. PubMed ID: 7482396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombophilia as a multigenic disease.
    Zöller B; García de Frutos P; Hillarp A; Dahlbäck B
    Haematologica; 1999 Jan; 84(1):59-70. PubMed ID: 10091393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated protein C resistance: molecular mechanisms.
    Griffin JH; Heeb MJ; Kojima Y; Fernández JA; Kojima K; Hackeng TM; Greengard JS
    Thromb Haemost; 1995 Jul; 74(1):444-8. PubMed ID: 8578503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of Arg306 mutations of factor V gene.
    Liang R; Lee CK; Wat MS; Kwong YL; Lam CK; Liu HW
    Blood; 1998 Oct; 92(7):2599-600. PubMed ID: 9746807
    [No Abstract]   [Full Text] [Related]  

  • 17. Portal vein thrombosis and factor V Arg 506 to Gln mutation.
    Levoir D; Emmerich J; Alhenc-Gelas M; Dumontier I; Petite JP; Fiessinger JN; Aiach M
    Thromb Haemost; 1995 Mar; 73(3):550-1. PubMed ID: 7667842
    [No Abstract]   [Full Text] [Related]  

  • 18. Factor V Arg506-->Gln mutation in patients with antiphospholipid antibodies.
    Montaruli B; Borchiellini A; Tamponi G; Giorda L; Bessone P; van Mourik JA; Voorberg J; Schinco P
    Lupus; 1996 Aug; 5(4):303-6. PubMed ID: 8869903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is "pseudo homozygous" for activated protein C resistance.
    Guasch JF; Lensen RP; Bertina RM
    Thromb Haemost; 1997 Feb; 77(2):252-7. PubMed ID: 9157576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on phospholipid antibodies, APC-resistance and associated mutation in the coagulation factor V gene.
    Bokarewa MI; Bremme K; Falk G; Sten-Linder M; Egberg N; Blombäck M
    Thromb Res; 1995 May; 78(3):193-200. PubMed ID: 7631299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.